Sclerostin, an osteocytes-derived bone-forming inhibitor.

Wlodarski, Krzysztof H; Galus, Ryszard; Brodzikowska, Aniela; Wlodarski, Pawel K

Wlodarski, Krzysztof H; Galus, Ryszard; Brodzikowska, Aniela; Wlodarski, Pawel K.

Affiliation

Wlodarski KH; Department of Histology and Embryology, Medical University of Warsaw, Warsaw, Poland. krzysztof.wlodarski@wum.edu.pl

Pol Orthop Traumatol ; 78: 151-4, 2013 Jul 01.

Article in En | MEDLINE | ID: mdl-23820854

Subject(s)

Bone Morphogenetic Proteins/biosynthesis; Osteocytes/cytology; Osteocytes/metabolism; Osteogenesis/physiology; Adaptor Proteins, Signal Transducing; Antibodies, Monoclonal/pharmacology; Bone Morphogenetic Proteins/antagonists & inhibitors; Cell Differentiation/physiology; Genetic Markers; Humans; Osteoporosis/physiopathology; Osteoporosis/prevention & control; Wnt Proteins/metabolism

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Osteocytes / Osteogenesis / Bone Morphogenetic Proteins Type of study: Prognostic_studies Limits: Humans Language: En Journal: Pol Orthop Traumatol Year: 2013 Document type: Article Affiliation country: Poland

Search on Google

Add to My VHL

XML

PubMed Links